GlobalData analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's ...

According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...

Nir Giladi from TAU’s Faculty of Medical and Health Sciences and the Tel Aviv Sourasky Medical Center, as well as other researchers from TAU and the University of Haifa. The study was backed by the ...

The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not ...

Aug. 19, 2024 — A small feasibility study found that an implanted device regulated by the body's brain activity could provide continual and improved treatment for the symptoms of Parkinson's ...

With rising demand and an ageing population, European healthcare systems are under strain. In the second article in our ...

While Parkinson’s disease (PD) has a large and highly generalised ... reflecting the field’s commitment to advancing ...

Early initiation of pimavanserin among patients with Parkinson disease psychosis were more likely to experience complete symptom resolution.

Among the symptoms, losing one's sense of smell could be an easily missed early indicator. The University of Auckland ...